A phase 2 study of epothilone B analog BMS-247550 (NSC 710428) in patients with relapsed aggressive non-Hodgkin lymphomas Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Epothilones
  • Lymphoma, Non-Hodgkin

abstract

  • Ixabepilone was well-tolerated, with neutropenia, peripheral sensory neuropathy, fatigue, and nausea as the major toxicities. Ixabepilone has modest single-agent activity in patients with recurrent chemosensitive aggressive lymphomas.

publication date

  • May 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4332882

Digital Object Identifier (DOI)

  • 10.1002/cncr.27917

PubMed ID

  • 23310949

Additional Document Info

start page

  • 1683

end page

  • 9

volume

  • 119

number

  • 9